Suppr超能文献

通过辅助生殖技术治疗男性不育症。

Management of male infertility by assisted reproductive technologies.

作者信息

Tournaye H

机构信息

Centre for Reproductive Medicine and Research Unit for Reproductive Biology, Dutch-speaking Free University, Brussels, Belgium.

出版信息

Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Sep;14(3):423-35. doi: 10.1053/beem.2000.0089.

Abstract

Among the most popular techniques of assisted reproduction for the treatment of male subfertility and infertility are intrauterine insemination, in vitro fertilization and intracytoplasmic sperm injection. The objective of these techniques is to bring more functional spermatozoa closer to the oocyte in order to promote fertilization. These techniques are thus not a cure per se and are only indicated when no specific or effective treatment is available for the male partner, when this treatment has failed or when the improvement of the female fertility status has also failed. While for moderate oligoasthenozoospermia, intrauterine insemination has proved to be a valid treatment, the outcome after conventional in vitro fertilization is limited because of a high incidence of complete fertilization failure. Since the introduction of intracytoplasmic sperm injection, a reliable method has become available in order to achieve fertilization in vitro. Apart from well from ejaculated spermatozoa, epididymal or testicular spermatozoa too can be used successfully for intracytoplasmic sperm injection. The surgical retrieval of spermatozoa for intracytoplasmic sperm injection has therefore become a routine technique in clinical andrology. Although these techniques have been implemented in everyday infertility practice within a few years of their introduction, many concerns about safety continue to exist. Intracytoplasmic sperm injection must be applied with caution, only when no other treatment option is available and when an appropriate prospective follow-up of the offspring is available.

摘要

用于治疗男性生育力低下和不育症的最常用辅助生殖技术包括宫内人工授精、体外受精和卵胞浆内单精子注射。这些技术的目的是使更多有功能的精子靠近卵母细胞,以促进受精。因此,这些技术本身并非治愈方法,仅在男性伴侣没有特定或有效治疗方法、该治疗失败或女性生育状况改善也失败时才适用。虽然对于中度少弱精子症,宫内人工授精已被证明是一种有效的治疗方法,但传统体外受精后的结果有限,因为完全受精失败的发生率很高。自从引入卵胞浆内单精子注射以来,一种可靠的体外受精方法已经出现。除了射出的精子外,附睾或睾丸精子也可以成功用于卵胞浆内单精子注射。因此,用于卵胞浆内单精子注射的精子手术采集已成为临床男科学的常规技术。尽管这些技术在引入后的几年内已应用于日常不育治疗实践中,但对安全性的诸多担忧仍然存在。卵胞浆内单精子注射必须谨慎应用,仅在没有其他治疗选择且对后代有适当的前瞻性随访时使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验